Mood, Stress
Conditions
Keywords
Sleep Quality, Magnesium
Brief summary
This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.
Interventions
DIETARY_SUPPLEMENTLiposomal Magnesium Complex
The supplement is taken in the morning with the first meal of the day for 14 consecutive days.
Sponsors
Cymbiotika, LLC
Citruslabs
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Be male or female * Be aged 18-60 * Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial. * Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period. * Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. * Resides in the United States.
Exclusion criteria
* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders. * Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients. * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * History of diagnosed psychiatric or mood disorders. * History of diagnosed sleep disorders. * History of serious illness in the last three months. * History of substance abuse. * History of kidney disease. * History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes. * Planned surgery during the study period. * Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration. * Anyone unwilling to follow the study protocol.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Energy Levels | Baseline, Day 3, Day 7, Day 10, Day 14 | Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires. |
| Change in Mood | Baseline, Day 3, Day 7, Day 10, Day 14 | Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Stress Levels | Baseline, Day 3, Day 7, Day 10, Day 14 | Participant-reported changes in perceived stress levels assessed via questionnaire. |
| Change in Relaxation and Calmness | Baseline, Day 3, Day 7, Day 10, Day 14 | Participant-reported changes in feelings of relaxation and calmness assessed via questionnaire. |
| Change in Balanced Mood | Baseline, Day 3, Day 7, Day 10, Day 14 | Participant perception of mood balance assessed using self-reported questionnaires. |
| Change in Sleep Quality | Baseline, Day 3, Day 7, Day 10, Day 14 | Participant-reported changes in sleep assessed via questionnaire. |
| Change in Muscle Tension | Baseline, Day 3, Day 7, Day 10, Day 14 | Participant-reported changes in muscle tension assessed using questionnaires. |
Countries
United States
Outcome results
None listed